Generate a tailored SOP for Dr. Håkan Axelson. Improve your application with a focused, well-structured draft.
Håkan Axelson is an Associate Professor at Lund University, leading the Kidney Cancer Research Group within the Division of Translational Cancer Research. His research primarily focuses on kidney cancer, especially clear cell renal cell carcinoma (ccRCC), which is characterized by the loss of the VHL tumor suppressor gene that leads to constitutive activation of the hypoxic response. Axelson's work aims to identify and characterize cell types involved in kidney cancer and their responses to hypoxia. His research has uncovered novel biomarkers like SLC6A3, with potential diagnostic and therapeutic implications. He has also demonstrated the role of hyperactivated Notch signaling in ccRCC progression. Axelson is actively engaged in projects associated with the UN Sustainable Development Goals and collaborates extensively on various cancer research initiatives.
Includes Master of Science in Politics and Society of the Contemporary Middle East and European Affairs.